CNTF-derived peptide

What is CNTF-derived peptide?

A neurotrophic research peptide related to CNTF pathway work; human clinical evidence remains limited.

This profile is educational. It organizes publicly discussed research context for CNTF-derived peptide and related naming aliases — it is not a treatment guide.

Proposed mechanism

Proposed to support neuronal plasticity and neurogenesis pathways studied in preclinical cognitive models.

Mechanism language on PepGuide describes how researchers discuss pathways. Proposed mechanisms can change as evidence evolves.

Current research notes

Human evidence grade: Insufficient evidence summarized

Preclinical evidence grade: Early-stage human research

P21/P021 appears in nootropic and neuropeptide research discussions. Robust human trials are lacking compared with approved neurology drugs.

Key uncertainties

• Human cognitive outcomes

Research areas being studied

• Cognitive research
• Neurotrophic signaling

Being studied for a topic is not the same as proven benefit in that topic. Prefer primary literature for study design, endpoints, and limitations.

Safety & side-effect notes

Reported or discussed adverse effects

• Insufficient systematic human data

Additional risks & considerations

• Unproven cognitive enhancement claims

Regulatory status

Research-stage

Regulatory framing here is educational and can lag policy changes. Check official sources for current status.

Frequently asked questions

References & sources

• Multiple authors (2015). CNTF-derived peptides in neurodegeneration models — Neuropharmacology. Evidence type: animal.